Global Central Venous Access Devices

Central Venous Access Devices Comprehensive Study by Type (Peripherally Inserted Central Catheter (PICC), Non-Tunnelled Catheter (CVC), Tunnelled Central Venous Catheter (Hickman), Implanted Port (Port-A-Cath), Others), Application (Medication Administration, Administration of Fluids Tand Nutritional Compounds, Transfusion of Blood Products, Diagnostic Testing), Duration (Dwell time, Short-term, Mid-term, Long-term), End User (Hospitals, Ambulatory Surgery Centers, Dialysis Centers, Others) Players and Region - Global Market Outlook to 2027

Central Venous Access Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Central Venous Access Devices
Central venous access devices (CVADs) are catheters inserted into peripheral veins or central veins in the chest, neck or groin, which travel through the venous system so the distal tip is positioned in the lower third of the superior vena cava, cavoatrial junction, or the upper right atrium. It can also be used to measure blood flow (hemodynamic monitoring), to draw blood, or for other reasons. An increase in the acute CVC market is expected to apply upward pressure to the value of the total CVC market over the forecast period.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Manufacturers will contribute the maximum growth to Global Central Venous Access Devices market throughout the forecasted period. Established and emerging Manufacturers should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Becton, Dickinson and Company (United States), Cook Medical Inc (United States), Teleflex Inc (United States), C. R. Bard, Inc. (United States), Smith’s Medical, Inc. (United Kingdom), Boston Scientifi (United States), MEDICON, INC. (Japan), Teleflex Incorporated (United States), Kawasumi Laboratories, Inc. (Japan), Covidien Plc (Ireland), OrbusNeich Medical (Japan), Becton Dickinson (United States), Argon Medical Devices Japan K.K. (Japan) and Medical Components Inc (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Central Venous Access Devices market by Type (Peripherally Inserted Central Catheter (PICC), Non-Tunnelled Catheter (CVC), Tunnelled Central Venous Catheter (Hickman), Implanted Port (Port-A-Cath) and Others), Application (Medication Administration, Administration of Fluids Tand Nutritional Compounds, Transfusion of Blood Products and Diagnostic Testing) and Region.



On the basis of geography, the market of Central Venous Access Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Duration, the sub-segment i.e. Dwell time will boost the Central Venous Access Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Central Venous Access Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advancements in Vascular Access Devices and Shifts in Preference Towards Acute CVCs and Away from Chronic CVCs

Market Growth Drivers:
Increasing Number of Lumens and Catheter Diameter, Growing Use of Vascular Access Devices in Pediatric Patients and Increasing use of Antimicrobial CVCs for High-risk Patients

Challenges:
Risks Related to Vascular Access Devices

Restraints:
Alternate technologies and their current use in clinical practice

Opportunities:
Increasing Focuses on Vascular Anastomosis Techniques and Arteriovenous Shunting and Innovation to Overcome the Shortcomings of Previous Technologies or Practices is an Ongoing Process By the Key Players

Market Leaders and their expansionary development strategies
On 6th Jan 2022, announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately USD 2.5 billion.



Key Target Audience
Blood Transfusion Devices Manufacturers, Blood Transfusion Devices Distributors/Traders/Wholesalers, Blood Transfusion Devices Subcomponent Manufacturers, Industry Association, Medical Institutes, Government Regulatory Bodies, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Peripherally Inserted Central Catheter (PICC)
  • Non-Tunnelled Catheter (CVC)
  • Tunnelled Central Venous Catheter (Hickman)
  • Implanted Port (Port-A-Cath)
  • Others
By Application
  • Medication Administration
  • Administration of Fluids Tand Nutritional Compounds
  • Transfusion of Blood Products
  • Diagnostic Testing
By Duration
  • Dwell time
  • Short-term
  • Mid-term
  • Long-term

By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Dialysis Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Lumens and Catheter Diameter
      • 3.2.2. Growing Use of Vascular Access Devices in Pediatric Patients
      • 3.2.3. Increasing use of Antimicrobial CVCs for High-risk Patients
    • 3.3. Market Challenges
      • 3.3.1. Risks Related to Vascular Access Devices
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Vascular Access Devices
      • 3.4.2. Shifts in Preference Towards Acute CVCs and Away from Chronic CVCs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Central Venous Access Devices, by Type, Application, Duration, End User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Central Venous Access Devices (Value)
      • 5.2.1. Global Central Venous Access Devices by: Type (Value)
        • 5.2.1.1. Peripherally Inserted Central Catheter (PICC)
        • 5.2.1.2. Non-Tunnelled Catheter (CVC)
        • 5.2.1.3. Tunnelled Central Venous Catheter (Hickman)
        • 5.2.1.4. Implanted Port (Port-A-Cath)
        • 5.2.1.5. Others
      • 5.2.2. Global Central Venous Access Devices by: Application (Value)
        • 5.2.2.1. Medication Administration
        • 5.2.2.2. Administration of Fluids Tand Nutritional Compounds
        • 5.2.2.3. Transfusion of Blood Products
        • 5.2.2.4. Diagnostic Testing
      • 5.2.3. Global Central Venous Access Devices by: Duration (Value)
        • 5.2.3.1. Dwell time
        • 5.2.3.2. Short-term
        • 5.2.3.3. Mid-term
        • 5.2.3.4. Long-term
      • 5.2.4. Global Central Venous Access Devices by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Ambulatory Surgery Centers
        • 5.2.4.3. Dialysis Centers
        • 5.2.4.4. Others
      • 5.2.5. Global Central Venous Access Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Central Venous Access Devices (Price)
      • 5.3.1. Global Central Venous Access Devices by: Type (Price)
  • 6. Central Venous Access Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cook Medical Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teleflex Inc (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. C. R. Bard, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Smith’s Medical, Inc. (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Boston Scientifi (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. MEDICON, INC. (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Teleflex Incorporated (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Kawasumi Laboratories, Inc. (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Covidien Plc (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. OrbusNeich Medical (Japan)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Becton Dickinson (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Argon Medical Devices Japan K.K. (Japan)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Medical Components Inc (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Central Venous Access Devices Sale, by Type, Application, Duration, End User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Central Venous Access Devices (Value)
      • 7.2.1. Global Central Venous Access Devices by: Type (Value)
        • 7.2.1.1. Peripherally Inserted Central Catheter (PICC)
        • 7.2.1.2. Non-Tunnelled Catheter (CVC)
        • 7.2.1.3. Tunnelled Central Venous Catheter (Hickman)
        • 7.2.1.4. Implanted Port (Port-A-Cath)
        • 7.2.1.5. Others
      • 7.2.2. Global Central Venous Access Devices by: Application (Value)
        • 7.2.2.1. Medication Administration
        • 7.2.2.2. Administration of Fluids Tand Nutritional Compounds
        • 7.2.2.3. Transfusion of Blood Products
        • 7.2.2.4. Diagnostic Testing
      • 7.2.3. Global Central Venous Access Devices by: Duration (Value)
        • 7.2.3.1. Dwell time
        • 7.2.3.2. Short-term
        • 7.2.3.3. Mid-term
        • 7.2.3.4. Long-term
      • 7.2.4. Global Central Venous Access Devices by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Ambulatory Surgery Centers
        • 7.2.4.3. Dialysis Centers
        • 7.2.4.4. Others
      • 7.2.5. Global Central Venous Access Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Central Venous Access Devices (Price)
      • 7.3.1. Global Central Venous Access Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Central Venous Access Devices: by Type(USD Million)
  • Table 2. Central Venous Access Devices Peripherally Inserted Central Catheter (PICC) , by Region USD Million (2016-2021)
  • Table 3. Central Venous Access Devices Non-Tunnelled Catheter (CVC) , by Region USD Million (2016-2021)
  • Table 4. Central Venous Access Devices Tunnelled Central Venous Catheter (Hickman) , by Region USD Million (2016-2021)
  • Table 5. Central Venous Access Devices Implanted Port (Port-A-Cath) , by Region USD Million (2016-2021)
  • Table 6. Central Venous Access Devices Others , by Region USD Million (2016-2021)
  • Table 7. Central Venous Access Devices: by Application(USD Million)
  • Table 8. Central Venous Access Devices Medication Administration , by Region USD Million (2016-2021)
  • Table 9. Central Venous Access Devices Administration of Fluids Tand Nutritional Compounds , by Region USD Million (2016-2021)
  • Table 10. Central Venous Access Devices Transfusion of Blood Products , by Region USD Million (2016-2021)
  • Table 11. Central Venous Access Devices Diagnostic Testing , by Region USD Million (2016-2021)
  • Table 12. Central Venous Access Devices: by Duration(USD Million)
  • Table 13. Central Venous Access Devices Dwell time , by Region USD Million (2016-2021)
  • Table 14. Central Venous Access Devices Short-term , by Region USD Million (2016-2021)
  • Table 15. Central Venous Access Devices Mid-term , by Region USD Million (2016-2021)
  • Table 16. Central Venous Access Devices Long-term , by Region USD Million (2016-2021)
  • Table 17. Central Venous Access Devices: by End User(USD Million)
  • Table 18. Central Venous Access Devices Hospitals , by Region USD Million (2016-2021)
  • Table 19. Central Venous Access Devices Ambulatory Surgery Centers , by Region USD Million (2016-2021)
  • Table 20. Central Venous Access Devices Dialysis Centers , by Region USD Million (2016-2021)
  • Table 21. Central Venous Access Devices Others , by Region USD Million (2016-2021)
  • Table 22. South America Central Venous Access Devices, by Country USD Million (2016-2021)
  • Table 23. South America Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 24. South America Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 25. South America Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 26. South America Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 27. Brazil Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 28. Brazil Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 29. Brazil Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 30. Brazil Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 31. Argentina Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 32. Argentina Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 33. Argentina Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 34. Argentina Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 35. Rest of South America Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 36. Rest of South America Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 37. Rest of South America Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 38. Rest of South America Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 39. Asia Pacific Central Venous Access Devices, by Country USD Million (2016-2021)
  • Table 40. Asia Pacific Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 41. Asia Pacific Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 42. Asia Pacific Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 43. Asia Pacific Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 44. China Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 45. China Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 46. China Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 47. China Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 48. Japan Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 49. Japan Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 50. Japan Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 51. Japan Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 52. India Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 53. India Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 54. India Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 55. India Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 56. South Korea Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 57. South Korea Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 58. South Korea Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 59. South Korea Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 60. Taiwan Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 61. Taiwan Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 62. Taiwan Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 63. Taiwan Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 64. Australia Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 65. Australia Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 66. Australia Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 67. Australia Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 69. Rest of Asia-Pacific Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 71. Rest of Asia-Pacific Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 72. Europe Central Venous Access Devices, by Country USD Million (2016-2021)
  • Table 73. Europe Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 74. Europe Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 75. Europe Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 76. Europe Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 77. Germany Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 78. Germany Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 79. Germany Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 80. Germany Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 81. France Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 82. France Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 83. France Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 84. France Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 85. Italy Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 86. Italy Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 87. Italy Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 88. Italy Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 89. United Kingdom Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 90. United Kingdom Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 91. United Kingdom Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 92. United Kingdom Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 93. Netherlands Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 94. Netherlands Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 95. Netherlands Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 96. Netherlands Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 97. Rest of Europe Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 98. Rest of Europe Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 99. Rest of Europe Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 100. Rest of Europe Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 101. MEA Central Venous Access Devices, by Country USD Million (2016-2021)
  • Table 102. MEA Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 103. MEA Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 104. MEA Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 105. MEA Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 106. Middle East Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 107. Middle East Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 108. Middle East Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 109. Middle East Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 110. Africa Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 111. Africa Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 112. Africa Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 113. Africa Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 114. North America Central Venous Access Devices, by Country USD Million (2016-2021)
  • Table 115. North America Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 116. North America Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 117. North America Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 118. North America Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 119. United States Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 120. United States Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 121. United States Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 122. United States Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 123. Canada Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 124. Canada Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 125. Canada Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 126. Canada Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 127. Mexico Central Venous Access Devices, by Type USD Million (2016-2021)
  • Table 128. Mexico Central Venous Access Devices, by Application USD Million (2016-2021)
  • Table 129. Mexico Central Venous Access Devices, by Duration USD Million (2016-2021)
  • Table 130. Mexico Central Venous Access Devices, by End User USD Million (2016-2021)
  • Table 131. Central Venous Access Devices: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Central Venous Access Devices: by Type(USD Million)
  • Table 147. Central Venous Access Devices Peripherally Inserted Central Catheter (PICC) , by Region USD Million (2022-2027)
  • Table 148. Central Venous Access Devices Non-Tunnelled Catheter (CVC) , by Region USD Million (2022-2027)
  • Table 149. Central Venous Access Devices Tunnelled Central Venous Catheter (Hickman) , by Region USD Million (2022-2027)
  • Table 150. Central Venous Access Devices Implanted Port (Port-A-Cath) , by Region USD Million (2022-2027)
  • Table 151. Central Venous Access Devices Others , by Region USD Million (2022-2027)
  • Table 152. Central Venous Access Devices: by Application(USD Million)
  • Table 153. Central Venous Access Devices Medication Administration , by Region USD Million (2022-2027)
  • Table 154. Central Venous Access Devices Administration of Fluids Tand Nutritional Compounds , by Region USD Million (2022-2027)
  • Table 155. Central Venous Access Devices Transfusion of Blood Products , by Region USD Million (2022-2027)
  • Table 156. Central Venous Access Devices Diagnostic Testing , by Region USD Million (2022-2027)
  • Table 157. Central Venous Access Devices: by Duration(USD Million)
  • Table 158. Central Venous Access Devices Dwell time , by Region USD Million (2022-2027)
  • Table 159. Central Venous Access Devices Short-term , by Region USD Million (2022-2027)
  • Table 160. Central Venous Access Devices Mid-term , by Region USD Million (2022-2027)
  • Table 161. Central Venous Access Devices Long-term , by Region USD Million (2022-2027)
  • Table 162. Central Venous Access Devices: by End User(USD Million)
  • Table 163. Central Venous Access Devices Hospitals , by Region USD Million (2022-2027)
  • Table 164. Central Venous Access Devices Ambulatory Surgery Centers , by Region USD Million (2022-2027)
  • Table 165. Central Venous Access Devices Dialysis Centers , by Region USD Million (2022-2027)
  • Table 166. Central Venous Access Devices Others , by Region USD Million (2022-2027)
  • Table 167. South America Central Venous Access Devices, by Country USD Million (2022-2027)
  • Table 168. South America Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 169. South America Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 170. South America Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 171. South America Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 172. Brazil Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 173. Brazil Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 174. Brazil Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 175. Brazil Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 176. Argentina Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 177. Argentina Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 178. Argentina Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 179. Argentina Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 180. Rest of South America Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 181. Rest of South America Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 182. Rest of South America Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 183. Rest of South America Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 184. Asia Pacific Central Venous Access Devices, by Country USD Million (2022-2027)
  • Table 185. Asia Pacific Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 186. Asia Pacific Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 187. Asia Pacific Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 188. Asia Pacific Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 189. China Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 190. China Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 191. China Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 192. China Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 193. Japan Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 194. Japan Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 195. Japan Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 196. Japan Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 197. India Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 198. India Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 199. India Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 200. India Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 201. South Korea Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 202. South Korea Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 203. South Korea Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 204. South Korea Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 205. Taiwan Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 206. Taiwan Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 207. Taiwan Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 208. Taiwan Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 209. Australia Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 210. Australia Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 211. Australia Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 212. Australia Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 213. Rest of Asia-Pacific Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 214. Rest of Asia-Pacific Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 215. Rest of Asia-Pacific Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 216. Rest of Asia-Pacific Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 217. Europe Central Venous Access Devices, by Country USD Million (2022-2027)
  • Table 218. Europe Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 219. Europe Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 220. Europe Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 221. Europe Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 222. Germany Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 223. Germany Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 224. Germany Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 225. Germany Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 226. France Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 227. France Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 228. France Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 229. France Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 230. Italy Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 231. Italy Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 232. Italy Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 233. Italy Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 234. United Kingdom Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 235. United Kingdom Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 236. United Kingdom Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 237. United Kingdom Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 238. Netherlands Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 239. Netherlands Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 240. Netherlands Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 241. Netherlands Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 242. Rest of Europe Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 243. Rest of Europe Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 244. Rest of Europe Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 245. Rest of Europe Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 246. MEA Central Venous Access Devices, by Country USD Million (2022-2027)
  • Table 247. MEA Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 248. MEA Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 249. MEA Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 250. MEA Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 251. Middle East Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 252. Middle East Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 253. Middle East Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 254. Middle East Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 255. Africa Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 256. Africa Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 257. Africa Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 258. Africa Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 259. North America Central Venous Access Devices, by Country USD Million (2022-2027)
  • Table 260. North America Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 261. North America Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 262. North America Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 263. North America Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 264. United States Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 265. United States Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 266. United States Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 267. United States Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 268. Canada Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 269. Canada Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 270. Canada Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 271. Canada Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 272. Mexico Central Venous Access Devices, by Type USD Million (2022-2027)
  • Table 273. Mexico Central Venous Access Devices, by Application USD Million (2022-2027)
  • Table 274. Mexico Central Venous Access Devices, by Duration USD Million (2022-2027)
  • Table 275. Mexico Central Venous Access Devices, by End User USD Million (2022-2027)
  • Table 276. Central Venous Access Devices: by Type(USD/Units)
  • Table 277. Research Programs/Design for This Report
  • Table 278. Key Data Information from Secondary Sources
  • Table 279. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Central Venous Access Devices: by Type USD Million (2016-2021)
  • Figure 5. Global Central Venous Access Devices: by Application USD Million (2016-2021)
  • Figure 6. Global Central Venous Access Devices: by Duration USD Million (2016-2021)
  • Figure 7. Global Central Venous Access Devices: by End User USD Million (2016-2021)
  • Figure 8. South America Central Venous Access Devices Share (%), by Country
  • Figure 9. Asia Pacific Central Venous Access Devices Share (%), by Country
  • Figure 10. Europe Central Venous Access Devices Share (%), by Country
  • Figure 11. MEA Central Venous Access Devices Share (%), by Country
  • Figure 12. North America Central Venous Access Devices Share (%), by Country
  • Figure 13. Global Central Venous Access Devices: by Type USD/Units (2016-2021)
  • Figure 14. Global Central Venous Access Devices share by Players 2021 (%)
  • Figure 15. Global Central Venous Access Devices share by Players (Top 3) 2021(%)
  • Figure 16. Global Central Venous Access Devices share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Becton, Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 20. Cook Medical Inc (United States) Revenue, Net Income and Gross profit
  • Figure 21. Cook Medical Inc (United States) Revenue: by Geography 2021
  • Figure 22. Teleflex Inc (United States) Revenue, Net Income and Gross profit
  • Figure 23. Teleflex Inc (United States) Revenue: by Geography 2021
  • Figure 24. C. R. Bard, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. C. R. Bard, Inc. (United States) Revenue: by Geography 2021
  • Figure 26. Smith’s Medical, Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Smith’s Medical, Inc. (United Kingdom) Revenue: by Geography 2021
  • Figure 28. Boston Scientifi (United States) Revenue, Net Income and Gross profit
  • Figure 29. Boston Scientifi (United States) Revenue: by Geography 2021
  • Figure 30. MEDICON, INC. (Japan) Revenue, Net Income and Gross profit
  • Figure 31. MEDICON, INC. (Japan) Revenue: by Geography 2021
  • Figure 32. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 33. Teleflex Incorporated (United States) Revenue: by Geography 2021
  • Figure 34. Kawasumi Laboratories, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Kawasumi Laboratories, Inc. (Japan) Revenue: by Geography 2021
  • Figure 36. Covidien Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 37. Covidien Plc (Ireland) Revenue: by Geography 2021
  • Figure 38. OrbusNeich Medical (Japan) Revenue, Net Income and Gross profit
  • Figure 39. OrbusNeich Medical (Japan) Revenue: by Geography 2021
  • Figure 40. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 41. Becton Dickinson (United States) Revenue: by Geography 2021
  • Figure 42. Argon Medical Devices Japan K.K. (Japan) Revenue, Net Income and Gross profit
  • Figure 43. Argon Medical Devices Japan K.K. (Japan) Revenue: by Geography 2021
  • Figure 44. Medical Components Inc (United States) Revenue, Net Income and Gross profit
  • Figure 45. Medical Components Inc (United States) Revenue: by Geography 2021
  • Figure 46. Global Central Venous Access Devices: by Type USD Million (2022-2027)
  • Figure 47. Global Central Venous Access Devices: by Application USD Million (2022-2027)
  • Figure 48. Global Central Venous Access Devices: by Duration USD Million (2022-2027)
  • Figure 49. Global Central Venous Access Devices: by End User USD Million (2022-2027)
  • Figure 50. South America Central Venous Access Devices Share (%), by Country
  • Figure 51. Asia Pacific Central Venous Access Devices Share (%), by Country
  • Figure 52. Europe Central Venous Access Devices Share (%), by Country
  • Figure 53. MEA Central Venous Access Devices Share (%), by Country
  • Figure 54. North America Central Venous Access Devices Share (%), by Country
  • Figure 55. Global Central Venous Access Devices: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson and Company (United States)
  • Cook Medical Inc (United States)
  • Teleflex Inc (United States)
  • C. R. Bard, Inc. (United States)
  • Smith’s Medical, Inc. (United Kingdom)
  • Boston Scientifi (United States)
  • MEDICON, INC. (Japan)
  • Teleflex Incorporated (United States)
  • Kawasumi Laboratories, Inc. (Japan)
  • Covidien Plc (Ireland)
  • OrbusNeich Medical (Japan)
  • Becton Dickinson (United States)
  • Argon Medical Devices Japan K.K. (Japan)
  • Medical Components Inc (United States)
Select User Access Type

Key Highlights of Report


Sep 2022 214 Pages 84 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Central Venous Access Devices Quantitative research analysis
Global Central Venous Access Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Becton, Dickinson and Company (United States), Cook Medical Inc (United States), Teleflex Inc (United States), C. R. Bard, Inc. (United States), Smith’s Medical, Inc. (United Kingdom), Boston Scientifi (United States), MEDICON, INC. (Japan), Teleflex Incorporated (United States), Kawasumi Laboratories, Inc. (Japan), Covidien Plc (Ireland), OrbusNeich Medical (Japan), Becton Dickinson (United States), Argon Medical Devices Japan K.K. (Japan) and Medical Components Inc (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Advancements in Vascular Access Devices " is seen as one of major influencing trends for Central Venous Access Devices Market during projected period 2021-2027.
The Central Venous Access Devices market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Central Venous Access Devices Report?

Have a Query? Click Here

Other Related Reports

Wireless Network Test Equipment Comprehensive Study by Application (Laptop, Mobilephone, Vehicle, Others), Network Type (2G, 3G, 4G, 5G, VoLTE), Equipment (Radio-frequency identification (RFID), ZigB...
$ 3800
Residential Water Treatment Equipment Comprehensive Study by Type (POU, POE), Application (Collection House, Detached House, Other) Players and Region - Global Market Outlook to 2026
$ 3500
Automatic Pool Cleaning Equipment Comprehensive Study by Type (Manual Brushing, Handheld Pool Vacuum, Automatic Suction Vacuums, Pressure Pool Vacuum, Robotic Pool Cleaner, In-Floor Vacuum System), A...
$ 3800
Exhaust Purification Device Comprehensive Study by Type (Three-way Catalyst, Oxidation Catalyst), Vehicle Type (Passenger car, Light commercial vehicle, Agricultural Machineries, Construction Equipme...
$ 3750
Automatic Weighing Machines Comprehensive Study by Type (Automatic Checkweighers, Automatic Catchweighers, Others), Application (Commercial, Industrial), Industry Verticals (Food & Beverages Industry...
$ 3650
Resin Wheel Comprehensive Study by Type (Straight Wheel, Cylinder or Wheel Ring, Tapered Wheel, Saucer Wheel, Diamond Wheels, Straight Cup, Dish Cup), Grain size (Coarse, Fine), End Users (Manufactur...
$ 3450